Turning Point Therapeutics | 4:持股變動聲明
2022/08/17 16:43 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/08/17 16:41 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/08/17 16:40 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/08/17 16:38 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/08/17 16:37 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/08/17 16:32 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/08/17 16:31 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/08/17 16:29 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/08/17 16:27 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/08/17 16:26 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/08/17 16:23 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/07/29 16:18 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/06/01 17:02 (美東)
Turning Point Therapeutics | 3:首次持股聲明-高管 Sabus Steve M
2022/06/01 16:59 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/04/12 18:46 (美東)
Turning Point Therapeutics | 3:首次持股聲明-高管 Sun Brian
2022/04/12 18:44 (美東)
Turning Point Therapeutics | SC 13G:超過5%持股股東披露文件-Cormorant Asset Management, LP(6.11%),Bihua Chen(6.11%)等
2022/02/14 15:02 (美東)
Turning Point Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(7.7%)
2022/02/14 14:35 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/02/11 18:11 (美東)
Turning Point Therapeutics | 4:持股變動聲明
2022/02/11 18:10 (美東)
暫無數據
暫無數據